Update for Quick Clinical Trials Reference Guide
Rockville, MD - A Quick Guide to Clinical Trials, 2nd Edition - extensively updated, with expanded coverage; edited by Drs. Madhu Davies and Faiz Kermani. With 16 subject matter expert authors and contributors, this is an excellent overview of the clinical trial process and drug development from an international perspective.
This new edition of the book has been extensively revised and re-written to include additional clinical trial topics and new subject matter to increase the breadth of discussion of this fascinating and dynamic discipline and yet continue to demystify the field in an exceptionally reader-friendly, yet authoritative format. The book strikes a good balance in providing background information and discussion themes for students and patients, while remaining authoritative and engaging for researchers and professionals.
Appropriately designed and executed clinical trials are at the heart of the successful drug development, but keeping pace with this rapidly evolving field and its complexity is a challenge for everyone involved. There remains a need for a friendly guide to cover the essential topic areas and explain their nuances while cutting through the technical jargon. With contributions by international industry leaders and subject matter experts, A Quick Guide to Clinical Trials, 2nd Edition effectively serves its purpose. Regardless of current level of understanding and prior knowledge, the book’s welcoming and easy to use format will ensure that anyone can find information of value to them and be able to apply it in practice.
"There's nothing like this Clinical Trials text out there...written by experts, easy to read by anyone!" - Steven E. Linberg, PhD, Adjunct Graduate Faculty, Johns Hopkins University
"This book is a well-presented, quick reference guide covering a broad range of important and relevant clinical trial-related topics...." - Dr. Ernest A. Kopecky, VP, Clinical Development; Head, Neuroscience, Collegium Pharmaceutical, Inc.
Teachers and instructors may receive a review copy by contacting the publisher.About BioPlan Associates
BioPlan Associates, Inc., has been providing information and publications to the biotechnology and pharmaceutical industry since 1989.
Moderna’s mRNA-1010 Flu Vaccine Meets Efficacy Goals in Phase III Trial of Adults 50+
July 10th 2025In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.
